This announcement is a separate document:
双成药业：海南双成药业股份有限公司董事会关于本次交易是否构成重大资产重组、关联交易及重组上市的说明
Shuangcheng Pharmaceutical: Explanation of the board of directors of Hainan Shuangcheng Pharmaceutical Co., Ltd. on whether this transaction constituted a major asset restructuring, related transaction and restructuring listing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.